InvestorsHub Logo
Followers 15
Posts 151
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Wednesday, 01/06/2021 9:16:16 AM

Wednesday, January 06, 2021 9:16:16 AM

Post# of 8287
AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications

Wed, January 6, 2021, 8:00 AM EST
NEW YORK, Jan. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applications. The technology is covered by four patent applications already on file with the United States Patent and Trademark Office.



https://finance.yahoo.com/news/aikido-pharma-inc-executes-licensing-130000571.html